Nevada State Board of Medical Examiners
1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559

OFFICE OF THE GENERAL COUNSEL


BEFORE THE BOARD OF MEDICAL EXAMINERS
OF THE STATE OF NEVADA


In the Matter of Charges and Case No. 17- 25257-1

Complaint Against FILED

Jorge Hernan Perez-Cardona, M.D.,
OCT 23 2017

NEVADA STATE BOARD OF

MEDIGAL EXAMINERS
By:

Respondent.

COMPLAINT

The Investigative Committee! (IC) of the Nevada State Board of Medical Examiners,
hereby issues this formal Complaint against Jorge Hernan Perez-Cardona, M.D. (hereinafter
referred to as Dr. Perez or Respondent), a licensed physician in Nevada. After investigating this
matter, the IC has a reasonable basis to believe that Respondent has violated provisions of Nevada
Revised Statutes (NRS) Chapter 630 and Nevada Administrative Code (NAC) Chapter 630
(collectively, the Medical Practice Act).

The IC alleges the following facts:

1. Respondent is a medical doctor currently licensed in active status (License No.
10108). Respondent was issued his license from the Nevada State Board of Medical Examiners
on March 13, 2002, pursuant to NRS Chapter 630.

A. Respondent’s Procuring and Administering of Drugs Not Approved by the FDA.

2. From about September 2011 to about February 2012, Respondent procured
controlled substances and dangerous drugs, as defined in Chapter 454 of NRS, that were not
approved by the United States Food and Drug Administration (FDA), including, but not limited to,
Aloxi, Mabthera and Altuzan (collectively, controlled substances/dangerous drugs), from a

pharmacy or pharmacies not licensed to sell controlled substances and dangerous drugs in the

1 The Investigative Committee of the Nevada State Board of Medical Examiners, at the time the filing of this
Complaint was approved, was composed of Wayne Hardwick, M.D., Theodore B. Berndt, M.D., and Mr. M. Neil

Duxbury.

OFFICE OF THE GENERAL COUNSEL

Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559


State of Nevada, and/or delegated to a medical assistant the task of procuring these
aforementioned controlled substances and dangerous drugs.

3, On information and belief, Respondent’s procurement, whether personally or by
his medical assistants at his direction, of the aforementioned controlled substances and dangerous
drugs that were not approved by the FDA and from a pharmacy or pharmacies not licensed to sell
controlled substances and dangerous drugs in the State of Nevada, was knowing and willful.

4. From about September 2011 to about February 2012, Respondent administered to
his patients, without verifying their permissible use, controlled substances and dangerous drugs, as
defined in Chapter 454 of NRS, that were not approved by the FDA, including, but not limited to,
Aloxi, Mabthera and Altuzan, or delegated to a medical assistant the task of verifying the
permissible use of the aforementioned.

5. On information and belief, Respondent’s administration of controlled substances
and dangerous drugs that were not approved by the FDA was knowing and willful.

6. Pursuant to NAC 630.810(a), a delegating practitioner may delegate to a medical
assistant the performance of a task if the delegating practitioner knows that the medical assistant
possesses the knowledge, skill and training to perform the task safely and properly, among other
requirements.

7. Pursuant to NAC 630.830, a delegating practitioner retains responsibility for the
safety and performance of each task which is delegated to a medical assistant.

Count I
NRS 630.306(1)(q)
(Knowingly or Willfully Procuring Controlled Substances
and Dangerous Drugs Not Approved by the FDA)

8. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

9. NRS 630.306(1)(q) provides that knowingly or willfully procuring a controlled
substance or a dangerous drug that is not approved by the FDA is grounds for initiating

disciplinary action or denying licensure.

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

Reno, Nevada 89502
(775) 688-2559

1105 Terminal Way #301


10. Respondent procured, personally or by medical assistant at his direction,
controlled substances and dangerous drugs that were not approved by the FDA, including, but not
limited to, Aloxi, Mabthera and Altuzan.

11. The controlled substances and dangerous drugs at issue were not procured through
a retail pharmacy licensed pursuant to Chapter 639 of NRS, or through a Canadian pharmacy
which is licensed pursuant to Chapter 639 of NRS and which has been recommended by the State
Board of Pharmacy pursuant to subsection 4 of NRS 639.2328, and were neither marijuana being
used for medical purposes in accordance with Chapter 453A of NRS, nor investigational drugs or
biological products prescribed to a patient pursuant to NRS 630.3735 or 633.6945.

12. Respondent’s conduct in procuring the controlled substances and dangerous drugs
at issue was knowing and willful.

13. By reason of the foregoing, Respondent is subject to discipline by the Nevada
State Board of Medical Examiners as provided in NRS 630.352.

Count IT
NRS 630.306(1)(q)
(Knowingly or Willfully Administering Controlled Substances
and Dangerous Drugs Not Approved by the FDA)

14. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

15. | NRS 630.306(1)(q) provides that knowingly or willfully administering a controlled
substance or a dangerous drug that is not approved by the FDA is grounds for initiating
disciplinary action or denying licensure.

16. | Respondent administered, personally or by medical assistant at his direction,
controlled substances and dangerous drugs that were not approved by the FDA.

17. The controlled substances and dangerous drugs at issue were not procured through
a retail pharmacy licensed pursuant to Chapter 639 of NRS, or through a Canadian pharmacy
which is licensed pursuant to Chapter 639 of NRS and which has been recommended by the State

Board of Pharmacy pursuant to subsection 4 of NRS 639.2328, and were neither marijuana being

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559


used for medical purposes in accordance with Chapter 453A of NRS, nor investigational drugs or
biological products prescribed to a patient pursuant to NRS 630.3735 or 633.6945.

18. Respondent’s conduct in administering the controlled substances and dangerous
drugs at issue was knowing and willful.

19. By reason of the foregoing, Respondent is subject to discipline by the Nevada
State Board of Medical Examiners as provided in NRS 630.352.

Count Il
NRS 630.306(1)(r)
(Failure to Adequately Supervise a Medical Assistant)

20. All of the allegations contained in the above paragraphs are hereby incorporated
by reference as though fully set forth herein.

21. Pursuant to NRS 630.306(1)(r), the failure to adequately supervise a medical
assistant pursuant to the regulations of the Board is grounds for initiating disciplinary action or
denying licensure.

22. Respondent failed to adequately supervise the medical assistant or assistants who
procured at his direction controlled substances and dangerous drugs that were not approved by the
FDA, including, but not limited to, Aloxi, Mabthera and Altuzan.

23. Pursuant to NAC 630.830, Respondent, as the delegating practitioner, is
professionally responsible for the conduct of his medical assistant or assistants who procured
controlled substances and dangerous drugs that were not approved by the FDA.

24. By reason of the foregoing, Respondent is subject to discipline by the Nevada
State Board of Medical Examiners as provided in NRS 630.352.

Count IV
NRS 630.306(1)(r)
(Failure to Adequately Supervise a Medical Assistant)

25. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.


OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559


26. Pursuant to NRS 630.306(1)(r), the failure to adequately supervise a medical
assistant pursuant to the regulations of the Board is grounds for initiating disciplinary action or
denying licensure.

27. Respondent failed to adequately supervise the medical assistant or assistants who
administered at his direction controlled substances and dangerous drugs, as defined in Chapter 454
of NRS, that were not approved by the FDA, including, but not limited to, Aloxi, Mabthera and
Altuzan.

28. Pursuant to NAC 630.830, Respondent, as the delegating practitioner, is
professionally responsible for the conduct of his medical assistant or assistants who administered,
without verifying their permissible use, controlled substances and dangerous drugs that were not
approved by the FDA.

29. By reason of the foregoing, Respondent is subject to discipline by the Nevada State
Board of Medical Examiners as provided in NRS 630.352.

WHEREFORE, the Investigative Committee prays:

l. That the Nevada State Board of Medical Examiners give Respondent notice of the
charges herein against him and give him notice that he may file an answer to the Complaint herein
as set forth in NRS 630.339(2) within twenty (20) days of service of the Complaint;

2. That the Nevada State Board of Medical Examiners set a time and place for a
formal hearing after holding an Early Case Conference pursuant to NRS 630.339(3);

3. That the Nevada State Board of Medical Examiners determine what sanctions to
impose if it determines there has been a violation or violations of the Medical Practice Act
committed by Respondent;

4, That the Nevada State Board of Medical Examiners make, issue and serve on
Respondent its findings of fact, conclusions of law and order, in writing, that includes the
sanctions imposed; and

5. That the Nevada State Board of Medical Examiners take such other and further
action as may be just and proper in these premises.


OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559



DATED this @5 day of October, 2017.

INVESTIGATIVE COMMITTEE OF
THE NEVADA STATE BOARD OF MEDICAL EXAMINERS

oe Ez

Robert Kilroy, Esq., General Counsel
Aaron Bart Fricke, Esq., Deputy General Counsel
Attorneys for the Investigative Committee

OFFICE OF THE GENERAL COUNSEL

Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559


VERIFICATION

STATE OF NEVADA )
COUNTY OF WASHOE )

Wayne Hardwick, M.D., having been duly sworn, hereby deposes and states under penalty
of perjury that he is the Chairman of the Investigative Committee of the Nevada State Board of
Medical Examiners that authorized the Complaint against the Respondent herein; that he has read
the foregoing Complaint; and that based upon information discovered in the course of the
investigation into a complaint against Respondent, he believes that the allegations and charges in
the foregoing Complaint against Respondent are true, accurate, and correct.

DATED hip? Jed day of October, 2017.

las Moacbond.

Wayne Hardwick, M.D.

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

1105 Terminal Way #301
Reno, Nevada 89502
(775) 688-2559


CERTIFICATE OF SERVICE
I hereby certify that I am employed by the Nevada State Board of Medical Examiners and

that on the 23 day of October, 2017, I served a file-stamped copy of the COMPLAINT and
FINGERPRINT INFORMATION, via USPS e-certified return receipt mail (9171 9690 0935 0096
3215 05) to the following:

Jorge Hernan Perez-Cardona, M.D.

1460 S. Curry Street, #100

Carson City, NV 89703

DATED this 23" day of October, 2017.

Ni bx

Kimberly ope Emvlove o

